CompletedNCT00367302
Buprenorphine or methadone treatment in jail and after release
About this title
Read the official source — NCT00367302Medication studyAges 18–65Addiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateAugust 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 116
- Sponsor
- National Development and Research Institutes, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00367302
- Official title
Show the full official title
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Development and Research Institutes, Inc.
Did this study involve medication?
Yes. The study involved medication, including buprenorphine and methadone.
Who was this study for?
Listed age limits: 18 years to 65 years.
